uniQure (QURE) Change in Account Payables (2016 - 2026)
uniQure's (QURE) quarterly Change in Account Payables came in at -$557000.0 in Q1 2026, up 73.39% year-on-year from -$321245.8 in Q1 2025, and up 45.34% quarter-over-quarter from -$1.0 million in Q4 2025.
uniQure (QURE) Change in Account Payables (2016 - 2026) Analysis & Trends
uniQure's Change in Account Payables history runs 11 years deep, the most recent figure standing at -$557000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 73.39% year-over-year to -$557000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 983.59% decrease from a year earlier, with the FY2025 full-year figure at -$2.7 million, down 275.46% from the prior year.
- Change in Account Payables rose to -$557000.0 in Q1 2026 per QURE's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.3 million in Q1 2022 and bottomed at -$3.6 million in Q3 2023.
- The 5-year median for Change in Account Payables is -$204000.0 (2025), against an average of $197941.2.
- Across the five-year window, Change in Account Payables jumped 272.49% in 2022 and tumbled 304.45% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $4.7 million in 2022, then plunged by 86.94% to $615000.0 in 2023, then soared by 230.41% to $2.0 million in 2024, then sank by 150.15% to -$1.0 million in 2025, then soared by 45.34% to -$557000.0 in 2026.
- Per Business Quant, the three latest QURE Change in Account Payables figures stand at -$557000.0 (Q1 2026), -$1.0 million (Q4 2025), and $649000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | - |
| 10 | uniQure | 2.41 Bn | 2.41 Bn | 3.34 Mn | -557,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -557,000.00 |
| Mar 31, 2026 | -557,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 649,000.00 |
| Sep 30, 2025 | 649,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -2.09 Mn |
| Mar 31, 2025 | -2.09 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | -918,000.00 |
| Jun 30, 2024 | -918,000.00 |
| Mar 31, 2024 | -701,000.00 |
| Mar 31, 2024 | -701,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Dec 31, 2023 | 615,000.00 |